Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
about
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaThe effect of dosing regimens on the antimalarial efficacy of dihydroartemisinin-piperaquine: a pooled analysis of individual patient dataBlocking malaria transmission to Anopheles mosquitoes using artemisinin derivatives and primaquine: a systematic review and meta-analysisGametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient dataNew developments in anti-malarial target candidate and product profilesTargeting asymptomatic malaria infections: active surveillance in control and eliminationAge, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children.Initiation of gametocytogenesis at very low parasite density in Plasmodium falciparum infection.Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial.Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?Molecular Markers for Sensitive Detection of Plasmodium falciparum Asexual Stage Parasites and their Application in a Malaria Clinical Trial.Longitudinal study on Plasmodium falciparum gametocyte carriage following artemether-lumefantrine administration in a cohort of children aged 12-47 months living in Western Kenya, a high transmission areaA review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmissionDirectional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.Comparison of detection methods to estimate asexual Plasmodium falciparum parasite prevalence and gametocyte carriage in a community survey in Tanzania.Artemisinin resistance--modelling the potential human and economic costs.Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis.Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan AfricaGenome-level determination of Plasmodium falciparum blood-stage targets of malarial clinical immunity in the Peruvian AmazonSplenic retention of Plasmodium falciparum gametocytes to block the transmission of malariaTailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community rAn Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in AfricaLack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan childrenA randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western KenyaHigh prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi.Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial.Modeling within-host effects of drugs on Plasmodium falciparum transmission and prospects for malaria elimination.Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Comparison of anti-malarial drugs efficacy in the treatment of uncomplicated malaria in African children and adults using network meta-analysis.Determinants of Malaria Transmission at the Population Level.The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa.Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial.Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrenceExamining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk.
P2860
Q24201077-C4878BB7-EB58-466E-AEF3-A2C3468AC1FAQ26822489-D08B970D-8E22-4BD7-9B75-BB87EEFE29D4Q27014789-F6E527DC-A808-47B4-BC3C-53AD8B1B4FC7Q28068072-58A8E08E-DB73-44CB-9856-EE410E9189DBQ28468598-67E68727-9032-4887-AF01-C6C55F57AB7DQ28534608-29850CEB-C254-4A72-B03F-1FF2BB0CAF5DQ33601837-EB24ADEE-BA87-46F4-823F-60B7BB6B1597Q33662226-9719B163-FEE3-4A08-B482-534A05E0F5B8Q33772980-02631792-A020-425B-9A8C-A7F71A37A867Q33874069-B200F862-E67A-4278-BBC6-CF9E2E7DEEA1Q33901814-D1AABBB7-4D78-4D42-8291-9A4898F6A314Q33928116-7264CCB4-8740-4BB9-9F68-6A56FEC59156Q34020818-E0791537-FE9A-464E-A8AA-004305D64CBCQ34563560-160FC590-5E2E-4BC1-8BF4-0D795ED3CCC3Q34582153-20C0198F-421C-4FEE-B815-4EB01D01EA47Q34623414-A8F35094-A790-4F6C-9F02-0C4FC09C4F08Q34677891-01E4F7F8-94D5-4DCE-8429-FF2B2723B7F2Q34922792-51DA921E-034C-464B-B36C-FD5CB88329F2Q35068138-52F55E70-7DB1-4AED-B571-8B1FB7449916Q35150299-12DBF6C7-57FD-4D8C-8E98-90853E2D99FBQ35473530-937C9CD5-D802-4315-8012-76F5D2E7EF8AQ35746071-DAF5D0C1-19B1-4DE8-BFB5-B417259A2371Q35860066-070D11C5-B2E5-415F-94BD-067717EDC381Q35948587-6348155D-AF5F-4A96-8A8F-447A9343F77CQ35949631-C3AC5202-CDC5-4171-8F1E-E2C636D223E0Q36436334-B7F12F8B-44D6-4FC1-B726-827998E64966Q36489713-0B351032-B77C-48C8-9598-684B1A41A53AQ37042465-D14A4F41-D0E1-45D9-BB25-E8659F55250EQ37394779-7AC6D550-BC20-4F0D-8360-77F19CDE010EQ37480626-4C4BC0C9-0427-4265-9D3A-AD08B1B1E96BQ37509562-011134F0-D879-4390-BC89-7652EEF00F42Q38245842-766374C5-086D-479E-861D-D5A9FA778D3AQ38529669-CF7D7371-B972-4E75-B8FD-3066CBD459E4Q38642887-2CC3A6E0-93A4-42BB-9D68-25C818C80E97Q38917744-139CF782-229F-4672-B556-488CB3A4586EQ39320463-37519EE9-4E78-45F1-89B1-D0401879E216Q39331198-2AD9D0A4-EFDB-43B3-8AA6-BEAC5CC88159Q42127740-28F686D2-95BD-421D-B017-3F572B80C63FQ42620908-254DBCBE-0EBD-41ED-B488-CE29971E9031Q42920110-189BD803-4B81-4936-86CC-8AB417C6CB8C
P2860
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Malaria transmission after art ...... peraquine: a randomized trial.
@en
Malaria transmission after art ...... peraquine: a randomized trial.
@nl
type
label
Malaria transmission after art ...... peraquine: a randomized trial.
@en
Malaria transmission after art ...... peraquine: a randomized trial.
@nl
prefLabel
Malaria transmission after art ...... peraquine: a randomized trial.
@en
Malaria transmission after art ...... peraquine: a randomized trial.
@nl
P2093
P2860
P50
P356
P1476
Malaria transmission after art ...... peraquine: a randomized trial.
@en
P2093
Alphaxard Manjurano
Amrish Y Baidjoe
Collins K Mweresa
Cornelus C Hermsen
Henk D F H Schallig
Patrick Sawa
Rachel L Hallett
Rahma U Yussuf
Reginald A Kavishe
Sabah A Omar
P2860
P304
P356
10.1093/INFDIS/JIT077
P407
P577
2013-03-06T00:00:00Z